Besides, the overall survival of glioma patients expressing high BCL7B was significantly worse than their counterparts expressing low BCL7B in CGGA and TCGA (HR = 2.706 and 3.560, respectively, all p < 0.05, Fig. 3). This evidence concerns the gene BCL7B and glioma.